Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes

Cryer, Philip E.·2012·Endocrinology

Cited by (241)

Items 201–241 of 241

  1. Target Discovery to Diabetes Therapy—TXNIP From Bench to Bedside With NIDDK
    Anath Shalev · 2025 · Endocrinology
  2. Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients
    Qiang Du, Yanjun Wang, Sheng Yang, Ping Han · 2015 · Patient Preference and Adherence
  3. Should I Stay or Should I Go: A Clash of α-Cell Identity
    Maria Sara Remedi · 2017 · Cell Metabolism
  4. Role of Automated Insulin Delivery (Artificial Pancreas) in Islet Transplantation: An In Silico Assessment
    Dayu Lv, José Garcia‐Tirado, Chiara Fabris · 2018 · OBM Transplantation
  5. Some anti-diabetic properties of Prosopis farcta extracts in alloxan induced diabetic in adult rats
    Ismael Mohammed, Ismail S. Kakey, Mahdi Moridi Farimani · 2020 · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences
  6. Double et triple agonistes : rôle du glucagon
    André Jacques Scheen · 2023 · Médecine des Maladies Métaboliques
  7. Glucagon in Islet and Metabolic Regulation
    Darleen A. Sandoval, Jenny Tong, David D' Alessio · 2016 · Wiley eBooks
  8. The Relationship Between Elevations in Glucocorticoids and Diabetes Development in Rats on Skeletal Muscle Insulin Resistance and the Microvasculature
    Emily C. Dunford · 2016 · YorkSpace (York University)
  9. Glucagon, physiologie et physiopathologie
    Céline Mouly · 2013 · Annales d Endocrinologie
  10. Assessment of β-Cell Function
    Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch · 2014 · Springer eBooks
  11. Does chronic leptin treatment decrease glucagon responsiveness in STZ-induced type 1 diabetic rats?
    Kristin E. Rowland · 2013
  12. POUR LE DIPLÔME D'ÉTAT DE DOCTEUR EN MÉDECINE
    Paul Sabatier, Facultés De Médecine, Médecine Spécialisée Clinique, Étienne Bally · 2013
  13. Hypoglycemia: A hard obstacle to overcome in diabetes management
    2020
  14. Defective Counterregulation and Hypoglycemia Unawareness in
    Candace M. Reno, Marina Litvin, Amy L. Clark, Simon J. Fisher · 2013
  15. Short cationic peptides for gene delivery into cancer cells
    Silvia Cirillo · 2017 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  16. Hormone Therapeutics – Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins ( H )
    Heinz Weinberger · 2017 · Ullmann's Encyclopedia of Industrial Chemistry
  17. Endocrine and Metabolic Emergencies in Transplantation
    Robert Alan Wermers, Pankaj R. Shah · 2018
  18. Glycaemic control in pregnancies complicated by type 1 diabetes
    Stewart, Zoe Alexandra · 2017 · Apollo (University of Cambridge)
  19. Role of insulin-degrading enzyme (IDE) in pancreatic beta-cell function: relevance in health and diabetes mellitus
    Cristina María Fernández Díaz · 2019
  20. Effect of fully automated closed‐loop insulin delivery using faster aspart versus standard aspart on gluco‐regulatory hormones in type 2 diabetes
    David Herzig, David Studer, Christos Theodoros Nakas, Christina Kuenzli, Thomas P. Stauffer, Roman Hovorka, Lia Bally · 2020 · Diabetes Obesity and Metabolism
  21. Metabolic and Electrophysiological Effects of Fibroblast Growth Factor 19 in the Dorsal Vagal Complex
    Jordan Wean · 2021 · UKnowledge (University of Kentucky)
  22. EXPLORING THE EFFECTS OF METABOLISM-DISRUPTING CHEMICALS ON PANCREATIC α-CELL BIOLOGY: A SCREENING TESTING APPROACH
    Ruba Al‐Abdulla, Hilda Ferrero, Talía Boronat‐Belda, Sergi Soriano, Iván Quesada, Paloma Alonso‐Magdalena · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Prospects for the use of drugs from the group of agonists of glucagon-like peptide-1 receptors in the treatment of non-alcoholic fatty liver disease
    Л. А. Суплотова, A. I. Fedorova, D. S. Kulmametova, Душина Татьяна Сергеевна, Olga Borisovna Makarova · 2023 · Meditsinskiy sovet = Medical Council
  24. Glucagon — new formulations as a chance for more effective treatment of severe hypoglycaemia
    Adrian Bystroń, Karolina Matuszewska · 2023 · Medical Research Journal
  25. Pengaruh Asupan Air pada Diabetes Melitus Tipe 2: Tinjauan Pustaka
    Handayani Eka Puspita Sari, Diana Sunardi, Krisadelfa Sutanto · 2023 · Intisari Sains Medis
  26. Glucagon in Islet and Metabolic Regulation
    Jonathan E. Campbell, David A. D’Alessio · 2024 · Wiley eBooks
  27. The association of fasting and postprandial GIP and glucagon levels with glycemic variability evaluated by flash glucose monitoring system in type 1 diabetes
    Afruz Babayeva, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, Füsun Baloş Törüner, Mehmet Ayhan Karakoç, Alev Eroğlu Altınova · 2024 · International Journal of Diabetes in Developing Countries
  28. Catechin Isolates from Gambir (Uncaria gambir Roxb) Maintain Glucose Homeostasis in Diabetic Model Rat
    Rauza Sukma Rita, Husna Yetti, Putra Santoso, Nita Afriani · 2024 · Medical Laboratory Technology Journal
  29. Salvia deserti Decne., an endemic and rare subshrub from Arabian desert: antidiabetic and antihyperlipidemic effects of leaf hydroethanolic extracts
    Arbi Guetat, Slimen Selmi, Abdelrahman Talha Abdelwahab, Marwa A. Abdelfattah, Abd Ealrhman M. Elhaj, Roaa T. Mogharbel, M. J. A. Abualreish, Abdullah F. Alanazi, Karim Hosni, Naceur Mejri et al. · 2025 · Frontiers in Pharmacology
  30. Existing pharmacological challenges and the need for improved therapies
    Rashmi Dubey, Sudhir Kumar Pandey, Triratnesh Gajbhiye, Mohineeta Pandey, Ankesh Tiwari, Ashish Kumar Tewari · 2025 · Elsevier eBooks
  31. Transcriptional and temporal heterogeneity of developing α cells revealed by single-cell RNA sequencing
    Naoya Shimizu, Tomomi Taguchi, Miwa Himuro, Iichiro Shimomura, Francis C. Lynn, Hirotaka Watada, Shugo Sasaki, Takeshi Miyatsuka · 2025 · Biochemical and Biophysical Research Communications
  32. Mitochondrial movement in pancreatic alpha cells requires Miro2 and is regulated by glucose
    Maia H. Ekstrand, Sameena Nawaz, Anne Clark, Benoît Hastoy, Jakob Grunnet Knudsen · 2025 · Journal of Biological Chemistry
  33. Additional file 2 of Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang, Cao, Jie, Jianbin Su, Wang, Xue-qin, Wang, Xing, Zhang, Dong-mei, Wang, Xiao-hua · 2021 · Figshare
  34. Additional file 3 of Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang, Cao, Jie, Su, Jian-bin, Wang, Xue-qin, Wang, Xing, Zhang, Dong-mei, Wang, Xiao-hua · 2021 · Figshare
  35. Additional file 1 of Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Wang, Hong, Cao, Jie, Su, Jian-bin, Wang, Xue-qin, Wang, Xing, Zhang, Dong-mei, Wang, Xiao-hua · 2021 · Figshare
  36. Additional file 4 of Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Hong Wang, Cao, Jie, Su, Jian-bin, Wang, Xue-qin, Wang, Xing, Zhang, Dong-mei, Wang, Xiao-hua · 2021 · Figshare
  37. Clinical and Etiological Peculiarities of Hypoglycemia in Patients with Diabetes
    Simona Georgiana Popa, Andreea Loredana Golli · 2025 · IntechOpen eBooks
  38. Hipoglisemi Farkındalığında Bozulma ve Hemşirelik Yaklaşımları
    Gamze Yeğin, Songül Karadağ · 2026 · Akdeniz Hemşirelik Dergisi
  39. Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
    Aya Abdul-Wahed · 2012 · theses.fr (ABES)
  40. Why glycemic control remains suboptimal in type 1 diabetes in the era of advanced technologies?
    Michaël Joubert · 2026 · Diabetes & Metabolism
  41. Early loss and progressive deterioration of glucagon responses to hypoglycemia in children with type 1 diabetes
    Antoine Harvengt, Maude Beckers, Ilektra Iakovidou, Anaïs Maure, Zain Syed, Laure Boutsen, Dominique Beckers, Philippe Antoine Lysy · 2026 · BMJ Open Diabetes Research & Care